[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hayes et al., 1979 - Google Patents

Le interferon production by human fibroblasts

Hayes et al., 1979

Document ID
6033520120513769573
Author
Hayes T
Yip Y
Vilček J
Publication year
Publication venue
Virology

External Links

Snippet

Human leukocyte (Le) and fibroblast (F) interferons differ in antigenic properties, physicochemical characteristics, and activity on cells of heterologous species. Previous work from this laboratory showed that two human foreskin fibroblast strains can produce either F …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2

Similar Documents

Publication Publication Date Title
Hayes et al. Le interferon production by human fibroblasts
Herrera et al. Association of protein C23 with rapidly labeled nucleolar RNA
Havell et al. Synthesis of two distinct interferons by human fibroblasts
Merigan et al. Purification and characterization of vertebrate interferons
De Ley et al. Interferon induced in human leukocytes by mitogens: production, partial purification and characterization
Grundy et al. Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes
Trinchieri et al. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
Tedeschi et al. Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells.
Duc-Goiran et al. Unusual apparently constitutive interferons and antagonists in human placental blood.
Oxman et al. The effect of interferon on SV40 T antigen production in SV40-transformed cells
Kerr et al. Translation of murine leukemia virus RNA in cell-free systems from animal cells
Pestka The purification and manufacture of human interferons
Larsson et al. Interferon production in glia and glioma cell lines
Rosner et al. Relationship of GIX antigen expression to the glycosylation of murine leukemia virus glycoprotein.
FI72143B (en) FOERFARANDE FOER FRAMSTAELLNING AV MAENNISKOINTERFERON
Gessani et al. Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon.
Havell Isolation of a subspecies of murine interferon antigenically related to human leukocyte interferon
Borden et al. The interferon refractory state: II. Biological characterization of a refractoriness-inducing protein
Fantes Interferons: purification and physicochemical aspects
Sadlik et al. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of γ-interferon
Hayes Differences between human α (leukocyte) and β (fibroblast) interferons
De Ley et al. Streptococcal preparation OK-432-induced interferon in human leukocytes: purification and characterization
Pang et al. Le interferon mRNA from human fibroblasts.
Morris et al. Spontaneous production of gamma interferon and induced production of beta interferon by human T-lymphoblastoid cell lines
Manjunath et al. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.